Evidence map›Paper›PMID 41929317›Full record

ArticlemedRxiv : the preprint server for health sciences2026

Domain-adapted language model using reinforcement learning for various dementias.

Sahana S Kowshik, Varuna H Jasodanand, Matteo Bellitti, Shreyas Puducheri, Lingyi Xu, Yi Liu, Ketan S Saichandran, Brigid C Dwyer, Audrey Gabelle, Honglin Hao and 11 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Sahana S KowshikFaculty of Computing & Data Sciences, Boston University, Boston, MA, USA.
Varuna H JasodanandDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Matteo BellittiDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Shreyas PuducheriDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Lingyi XuFaculty of Computing & Data Sciences, Boston University, Boston, MA, USA.
Yi LiuFaculty of Computing & Data Sciences, Boston University, Boston, MA, USA.
Ketan S SaichandranDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Brigid C DwyerDepartment of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Audrey GabelleMemory Resource and Research Center of Montpellier, CHU de Montpellier, Hôpital Gui de Chauliac, Montpellier, France.
Honglin HaoDepartment of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Sachin KedarDepartments of Neurology & Ophthalmology, Emory University School of Medicine, Atlanta, GA, USA.
Daniel L MurmanDepartment of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
Sarah A O'SheaDepartment of Neurology, Icahn School of Medicine, New York, NY, USA.
Marie-Helene Saint-HilaireDepartment of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Niyatee P SamudraDepartment of Neurology and Neurological Sciences, Stanford University School of Medicine, Palo Alto, CA, USA.
Emmett A SartorDepartment of Neurology, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Arun SwaminathanDepartment of Neurology, SSM Health, Madison, WI, USA.
Olga TaraschenkoDepartment of Neurological Sciences, University of Nebraska Medical Center, Omaha, NE, USA.
Jing YuanDepartment of Neurology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.
Rhoda AuDepartment of Medicine, Boston University Chobanian & Avedisian School of Medicine, Boston, MA, USA.
Vijaya B KolachalamaFaculty of Computing & Data Sciences, Boston University, Boston, MA, USA.ORCID 0000-0002-5312-8644

Funding

Alzheimer's Disease Neuroimaging Initiative - SupplementU01AG024904 · NIA · NORTHERN CALIFORNIA INSTITUTE RES &EDUC · PI WEINER, MICHAEL W · 2004 to 2015
$121.0M
National Alzheimer's Coordinating CenterU24AG072122 · NIA · UNIVERSITY OF WASHINGTON · PI STEPHENS, KARI A · 2021 to 2025
$45.8M
Research Education ComponentP30AG062422 · NIA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Katherine P Rankin · 2019 to 2026
$36.9M
Research Education ComponentP30AG062421 · NIA · MASSACHUSETTS GENERAL HOSPITAL · PI BRADFORD C DICKERSON · 2019 to 2026
$36.5M
UCSD Shiley-Marcos Alzheimer's Disease Research Center P30P30AG062429 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI DOUGLAS R GALASKO · 2019 to 2026
$34.9M
Wisconsin Alzheimer's Disease Research CenterP30AG062715 · NIA · UNIVERSITY OF WISCONSIN-MADISON · PI Sanjay Asthana · 2019 to 2026
$34.5M
Research Education ComponentP30AG062677 · NIA · MAYO CLINIC ROCHESTER · PI KEJAL KANTARCI · 2019 to 2026
$33.5M
Utilizing Technology and AI Approaches to Facilitate Independence andResilience in Older AdultsP30AG073104 · NIA · JOHNS HOPKINS UNIVERSITY · PI Alexis Battle · 2021 to 2026
$31.2M
Research Education ComponentP30AG066514 · NIA · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI Margaret Sewell · 2020 to 2026
$31.0M
Yale Alzheimer Disease Research CenterP30AG066508 · NIA · YALE UNIVERSITY · PI STEPHEN M STRITTMATTER · 2020 to 2026
$30.2M
Research Education CoreP30AG066462 · NIA · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI PHILIP L DE JAGER · 2020 to 2026
$30.1M
Research Education ComponentP30AG066468 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI C. Elizabeth Shaaban · 2020 to 2026
$29.4M
NHLBI NIH HHS R01 HL159620NIA NIH HHS P20 AG068024NIA NIH HHS P20 AG068053NIA NIH HHS P20 AG068077NIA NIH HHS P20 AG068082NIA NIH HHS P30 AG062421NIA NIH HHS P30 AG062422NIA NIH HHS P30 AG062429NIA NIH HHS P30 AG062677NIA NIH HHS P30 AG062715NIA NIH HHS P30 AG066444NIA NIH HHS P30 AG066462NIA NIH HHS P30 AG066468NIA NIH HHS P30 AG066506NIA NIH HHS P30 AG066507NIA NIH HHS P30 AG066508NIA NIH HHS P30 AG066509NIA NIH HHS P30 AG066511NIA NIH HHS P30 AG066512NIA NIH HHS P30 AG066514NIA NIH HHS P30 AG066515NIA NIH HHS P30 AG066518NIA NIH HHS P30 AG066519NIA NIH HHS P30 AG066530NIA NIH HHS P30 AG066546NIA NIH HHS P30 AG072931NIA NIH HHS P30 AG072946NIA NIH HHS P30 AG072947NIA NIH HHS P30 AG072958NIA NIH HHS P30 AG072959NIA NIH HHS P30 AG072972NIA NIH HHS P30 AG072973NIA NIH HHS P30 AG072975NIA NIH HHS P30 AG072976NIA NIH HHS P30 AG072977NIA NIH HHS P30 AG072978NIA NIH HHS P30 AG072979NIA NIH HHS P30 AG073104NIA NIH HHS P30 AG073105NIA NIH HHS R01 AG032306NIA NIH HHS R01 AG062109NIA NIH HHS R01 AG079280NIA NIH HHS R01 AG083735NIA NIH HHS U01 AG024904NIA NIH HHS U24 AG072122NINDS NIH HHS R01 NS142076
6 · The paper itself

Abstract

Large language models excel at processing complex clinical data and advanced reasoning, yet domain-specific adaptation is essential to realize their full potential in fields such as Alzheimer's disease and related dementias (ADRD). Here, we present a generative language model for ADRD fine-tuned via reinforcement learning with verifiable rewards using a self-certainty-aware advantage. Model development and validation leveraged data from five ADRD cohorts, totaling 54, 535 participants. Our framework integrates demographics, personal and family medical histories, medication use, neuropsychological test results, functional assessments, physical and neurological examination findings, laboratory data and multimodal neuroimaging to construct comprehensive clinical profiles. On held-out testing data involving 36, 688 participants, our model achieved robust performance on syndromic classification, primary etiological diagnosis and biomarker prediction. Model predictions were validated against postmortem-confirmed diagnoses, and clinical utility was demonstrated in a controlled within-subjects crossover study where board-certified neurologists reviewed cases with and without model assistance, showing that exposure to model responses improved diagnostic performance. These results demonstrate that targeted domain adaptation with reinforcement learning can enable language models to deliver accurate, reasoning-driven support in ADRD evaluation. Prospective validation will be essential to translate these advances into improved patient outcomes.

Identifiers

PMID41929317
PMCPMC13042137

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.